Monitoring the immune competence of cancer patients to predict outcome.
about
Novel technologies and emerging biomarkers for personalized cancer immunotherapyThe potential of tumor-derived exosomes for noninvasive cancer monitoringThe FDA guidance on therapeutic cancer vaccines: the need for revision to include preventive cancer vaccines or for a new guidance dedicated to themT Cell Subpopulations in Healthy Elderly and Lung Cancer Patients: Insights from Cuban Studies.CIMAvax-EGF: A New Therapeutic Vaccine for Advanced Non-Small Cell Lung Cancer Patients.Immunotherapy biomarkers 2016: overcoming the barriers.Immunomonitoring in glioma immunotherapy: current status and future perspectives.Emerging immunotherapy for the treatment of esophageal cancer.Dysfunction of PSA-specific CD8+ T cells in prostate cancer patients correlates with CD38 and Tim-3 expression.Biomarkers related to immunosenescence: relationships with therapy and survival in lung cancer patients.CyTOF Measurement of Immunocompetence Across Major Immune Cell Types.Tumor-derived exosomes in ovarian cancer - liquid biopsies for early detection and real-time monitoring of cancer progression.Immune checkpoint targeting as anti-cancer immunotherapy: promises, questions, challenges and the need for predictive biomarkers at ASCO 2015.The Immunome of Colon Cancer: Functional In Silico Analysis of Antigenic Proteins Deduced from IgG Microarray Profiling.PD-L1 expression and presence of TILs in small intestinal neuroendocrine tumours.Melanoma Immunotherapy: Next-Generation Biomarkers.
P2860
Q26770780-0D10C888-33D8-4486-85C4-D19620302A90Q26796396-D38C4E92-3F3A-4096-BFB0-4AD6B008E3BBQ36248790-9E73B63E-88E9-408D-8CB0-6141D0FB8390Q37639755-ED04AD72-66F3-4BC6-86FF-CAE706CF622DQ37695065-45D120DC-B7BA-4465-B83C-6454688B9C1AQ37713438-56F36ED0-BCA4-42EE-8163-4D9542580E16Q38659771-7A2A6CFF-B4E1-4F78-93C4-E3CC88B5C433Q38763851-F19F4AC4-6BD6-4D41-B916-6E4D5A883E6EQ40626645-D1E9EE0A-C953-4ADB-9B5D-94680911014CQ41109485-B5DE677E-32D2-45E2-97D6-2642DFBADA87Q45930699-89E7ED71-F68E-453D-AD1B-2BD7B21FB409Q47134018-E4DAA9D7-95A5-43AA-A921-754519AB3EC0Q51286243-DD8FC8CC-8973-4ACE-AF59-8564200FE0F6Q52367069-C1B08878-2FDE-4DFA-B560-A2159831C236Q52723008-0DF953D0-9CB3-43BD-B030-0F0871502B26Q55156734-F0DBEB12-15FA-4E97-AE48-AC1DCCA24C96
P2860
Monitoring the immune competence of cancer patients to predict outcome.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Monitoring the immune competence of cancer patients to predict outcome.
@en
type
label
Monitoring the immune competence of cancer patients to predict outcome.
@en
prefLabel
Monitoring the immune competence of cancer patients to predict outcome.
@en
P2093
P2860
P1476
Monitoring the immune competence of cancer patients to predict outcome.
@en
P2093
Holbrook Kohrt
Holden T Maecker
Serena Chang
P2860
P2888
P304
P356
10.1007/S00262-014-1521-3
P577
2014-02-01T00:00:00Z
P6179
1030937316